Hepatitis C therapy at home: a hospital and home care partnership

Area of Science:

• Hepatology
• Public Health
• Healthcare Management

Background:

• Hepatitis C virus (HCV) poses a significant public health challenge in the UK, characterized by underdiagnosis and undertreatment.
• Current HCV management in secondary and tertiary centers presents barriers for patients, including travel burdens, costs, long waiting times, and work-related scheduling issues.
• Decentralizing care to the home setting can improve patient access and treatment acceptance, particularly for those in remote areas.

Purpose of the Study:

• To assess the feasibility, safety, and efficacy of a home-based HCV treatment model.
• To evaluate the impact of a partnership between secondary care and a clinical home care company on HCV patient management.
• To compare the home care model's outcomes with traditional clinic-based care.

Main Methods:

• A collaborative model involving secondary care specialists and a clinical home care company was implemented for HCV treatment.
• Feasibility, safety, and efficacy of home-based treatment were systematically evaluated.
• Patient attendance rates were compared between the home care model and the conventional clinic model.

Main Results:

• The home care model demonstrated a significantly higher attendance rate compared to the standard clinic model.
• The initiative successfully improved patient care delivery without incurring extra costs for the healthcare trust.
• The model allows for the optimization of specialist nurse resources, enabling them to attend to patients with more complex conditions.

Conclusions:

• Home-based HCV treatment is a feasible, safe, and effective approach to improve patient access and adherence.
• This collaborative model enhances healthcare efficiency and patient outcomes in HCV management.
• The strategy optimizes specialist nurse utilization, focusing expertise on complex cases and improving overall care delivery.